The Safety and Efficacy of Embotrap in Treating Acute Ischemic Stroke Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 330 participants.
Also called NCT05667103
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 330 participants
- Sponsor
- Registry
-
NCT05667103
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05667103. Randomized; quadruple masking; primary purpose treatment. Start 2023-01-15 (actual); primary completion 2024-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Safety and Efficacy of Embotrap in Treating Acute Ischemic Stroke Patients
- Condition
- Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Device)
- Embotrap stent retriever
- Intervention (Device)
- Solitaire FR, Trevo stent retriever without inner channel
- Lead sponsor
- Xuanwu Hospital, Beijing
Record details
- Record id
cardio:ct-nct05667103- Content hash
16ccec26e52d714c5b3dd1f71fb7da3061ba585d1208cff631104d71dbee5522